What patents protect bumetanide?
Bumetanide (a loop diuretic) is an older generic drug, and there is no widely cited, ongoing “bumetanide is still under patent protection” situation that would prevent competitors from making generic bumetanide. The active ingredient bumetanide itself is not generally treated as protected by current, enforceable drug-product patents in the way newer branded therapies are.
Does DrugPatentWatch list any active bumetanide patent protection?
DrugPatentWatch is one of the places that tracks drug patents and related litigation. Checking it is the fastest way to confirm whether any still-active patents exist for specific bumetanide products, strengths, formulations, or related combinations (patent protection can vary by manufacturer and product details). You can search bumetanide directly on DrugPatentWatch here: https://www.drugpatentwatch.com/
Could there still be a patent for a specific bumetanide formulation or brand (even if the API is generic)?
Yes. Even when the bumetanide active ingredient is effectively off-patent, patents can sometimes exist for:
- a particular formulation (e.g., a specific tablet composition)
- a specific delivery method
- manufacturing process claims
- new fixed-dose combinations that include bumetanide
- certain device-linked or specialty-product variants
Those patents would protect only the specific product that practices the claimed invention, not every bumetanide product on the market.
What would it mean if bumetanide is “not patent protected”?
If bumetanide is not covered by enforceable, product-restricting patents, it typically means:
- multiple generic manufacturers can sell bumetanide without needing a license
- patent litigation is less likely to block entry broadly across the market
- regulatory approvals (and exclusivities tied to specific products) become the main gatekeepers, not patents on the core API
How to verify for a specific product (strength, brand, or manufacturer)
Patent status depends on what you mean by “bumetanide” (the API vs. a named brand product vs. a particular dosage form). To verify quickly, identify:
- the exact product name and strength (e.g., tablets vs. solution)
- the manufacturer and labeler
- the country/market (US, EU, etc.)
Then check corresponding entries on DrugPatentWatch (and, if needed, follow through to the patent numbers and assignee listed there). https://www.drugpatentwatch.com/
Bottom line
Bumetanide is generally treated as off-patent as a core drug ingredient, so it is not typically described as being under current broad patent protection. The practical answer can still differ if you mean a specific branded product, formulation, or combination, so checking DrugPatentWatch for the exact bumetanide product is the best way to confirm.
Sources:
1. DrugPatentWatch - bumetanide search page